In addition to promoting cancer cell proliferation and survival, NF-κB activation is also involved in epithelial-to-mesenchymal transition (EMT), invasion, angiogenesis, metastasis, stemness acquisition, and therapeutic resistance (9–11). This evidence concerns the gene NFKB1 and cancer.